愛(ai)科藥(yao)業成(cheng)立于2002年(nian)9月9日,已(yi)發(fa)展成(cheng)為集生(sheng)產(chan)(chan)(chan)(chan)(chan)、研發(fa)、銷售為一體,擁(yong)(yong)有一家(jia)現(xian)代(dai)化藥(yao)品生(sheng)產(chan)(chan)(chan)(chan)(chan)企業,兩(liang)家(jia)全國性的藥(yao)品經營(ying)企業,一家(jia)藥(yao)物研究(jiu)所,形成(cheng)新型的藥(yao)業集團(tuan)。2008年(nian)6月30日,公(gong)司新建生(sheng)物工(gong)程(cheng)項(xiang)目(mu)總(zong)投資1.8億元。擴(kuo)建項(xiang)目(mu)擁(yong)(yong)有:年(nian)產(chan)(chan)(chan)(chan)(chan)1500萬(wan)(wan)支(zhi)瓶裝大(da)容(rong)(rong)量注射液生(sheng)產(chan)(chan)(chan)(chan)(chan)線(xian);年(nian)產(chan)(chan)(chan)(chan)(chan)3000萬(wan)(wan)支(zhi)非PVC大(da)容(rong)(rong)量注射液生(sheng)產(chan)(chan)(chan)(chan)(chan)線(xian);年(nian)產(chan)(chan)(chan)(chan)(chan)800萬(wan)(wan)支(zhi)乳劑生(sheng)產(chan)(chan)(chan)(chan)(chan)線(xian);年(nian)產(chan)(chan)(chan)(chan)(chan)2億支(zhi)外(wai)用(yong)藥(yao)生(sheng)產(chan)(chan)(chan)(chan)(chan)線(xian);年(nian)產(chan)(chan)(chan)(chan)(chan)2000萬(wan)(wan)支(zhi)凍干粉針生(sheng)產(chan)(chan)(chan)(chan)(chan)線(xian)。
未來,愛科藥(yao)業的(de)企業發展方向(xiang)是在重大挑戰領(ling)域里創造(zao)創新藥(yao)物,成為(wei)(wei)中國創新藥(yao)物開發的(de)領(ling)跑者。正(zheng)凝聚(ju)更多力量,為(wei)(wei)患者尋求和(he)提(ti)供更有(you)效藥(yao)物,讓員工為(wei)(wei)此(ci)而(er)自(zi)豪,從而(er)贏得客戶和(he)社會(hui)的(de)尊重。